Skip to main content
. 2016 Apr 4;5(4):e214. doi: 10.1038/oncsis.2016.23

Figure 12.

Figure 12

FOXO3 and EZH2 expression levels in breast cancers with different BRCA mutation. (a) Comparison of FOXO3 expression levels with different BRCA mutation status by Mann–Whitney U-rank test using all samples. (b) Comparison of FOXO3 expression levels with different BRCA mutation status using samples that express low levels of nuclear EZH2 by Mann–Whitney U-rank test. (c) Comparison of FOXO3 expression levels with different BRCA mutation status compared using samples that express high levels of nuclear EZH2 by Mann–Whitney U-rank test.